Document is current
Any future updates will be listed below
-
Authors
Malysheva, Valeriya https://orcid.org/0000-0002-0919-7845
Ray-Jones, Helen
Lakes, Nora
Brown, Rachel A.
Cazares, Tareian A.
Clay, Owen
Ohayon, David E.
Artemov, Pavel https://orcid.org/0000-0001-6699-6400
Wayman, Joseph A.
Yang, Zi F.
Della Rosa, Monica
Petitjean, Carmen https://orcid.org/0000-0002-7687-4447
Booth, Clarissa
Ellaway, Joseph I. J. https://orcid.org/0000-0002-6670-5391
Barnes, Jenna R.
Dangel, Andrew W.
Saini, Ankita https://orcid.org/0009-0000-3694-495X
Orchard, William R.
Chen, Xiaoting https://orcid.org/0000-0002-3782-3962
Parameswaran, Sreeja
Burden, Frances
Frontini, Mattia https://orcid.org/0000-0001-8074-6299
Nagano, Takashi
Fraser, Peter
Schoenfelder, Stefan https://orcid.org/0000-0002-3200-8133
Weirauch, Matthew T. https://orcid.org/0000-0001-7977-9122
Kottyan, Leah C. https://orcid.org/0000-0003-3979-2220
Smith, David F. https://orcid.org/0000-0002-0048-4012
Powell, Nick https://orcid.org/0000-0003-3231-6950
Weimer, Jill M.
Oltz, Eugene M.
Wallace, Chris https://orcid.org/0000-0001-9755-1703
Miraldi, Emily R. https://orcid.org/0000-0002-0232-3116
Waggoner, Stephen N. https://orcid.org/0000-0001-9658-2874
Spivakov, Mikhail https://orcid.org/0000-0002-0383-3943
-
Funding
Funding for this research was provided by:
RCUK | Medical Research Council (MC-A652-5QA20)
- License Information
-
More Information
Article History
Received: 28 October 2022
Accepted: 17 June 2026
First Online: 4 August 2026
Ethics
Competing interests: P.F., S.S. and M.S. are shareholders of Enhanced Genomics Ltd. J.M.W. is an employee of Amicus Therapeutics, Inc., and holds equity in the company in the form of stock-based compensation; Amicus had no input into this work. C.W. is also an employee of GSK; GSK had no input into this work. C.P. is an employee of Vitaccess; Vitaccess had no input into this work. M.D.R. is an employee of NeoGenomics Laboratories Inc.; NeoGenomics Laboratories had no input into this work. V.M., M.S., S.S., T.N. and P.F. are coinventors on a patent (WO2021064430A1) filed by the Babraham Institute that describes the low-input PCHi-C technology. The remaining authors declare no competing interests.
